Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Pharmacoepidemiology and Drug Safety
|
February 1, 2008
Data incompatibility of adverse event reports electronically submitted to the AERS database
Lucas M Glass
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
ClinicalTrials.gov: An Underutilized Source of Research Data About the Design and Conduct of Commercial Clinical Trials
Harold E Glass, Lucas M Glass, Jeffrey J DiFrancesco
IEEE Transactions on Knowledge and Data Engineering
|
January 2, 2023
MOLER: Incorporate Molecule-Level Reward to Enhance Deep Generative Model for Molecule Optimization
Tianfan Fu, Cao Xiao, Lucas M Glass, et al.
Journal of the American Medical Informatics Association : JAMIA
|
June 18, 2020
Dr. Agent: Clinical predictive model via mimicked second opinions
Junyi Gao, Cao Xiao, Lucas M Glass, et al.
Bioinformatics (Oxford, England)
|
October 18, 2020
MolTrans: Molecular Interaction Transformer for drug-target interaction prediction
Kexin Huang, Cao Xiao, Lucas M Glass, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Pharmaceutical Organizational Size and Phase 3 Clinical Trial Completion Times
Harold E Glass, Lucas M Glass, Phuong Tran, et al.
Scientific Reports
|
December 4, 2020
SkipGNN: predicting molecular interactions with skip-graph networks
Kexin Huang, Cao Xiao, Lucas M Glass, et al.
Patterns (New York, N.Y.)
|
April 25, 2022
HINT: Hierarchical interaction network for clinical-trial-outcome predictions
Tianfan Fu, Kexin Huang, Cao Xiao, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Are Phase 3 Clinical Trials Really Becoming More Complex?
Harold E Glass, Jeffrey J DiFrancesco, Lucas M Glass, et al.
Journal of the American Medical Informatics Association : JAMIA
|
October 30, 2020
FLANNEL (Focal Loss bAsed Neural Network EnsembLe) for COVID-19 detection
Zhi Qiao, Austin Bae, Lucas M Glass, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Pharmacoepidemiology and Drug Safety
|
February 1, 2008
Data incompatibility of adverse event reports electronically submitted to the AERS database
Lucas M Glass
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
ClinicalTrials.gov: An Underutilized Source of Research Data About the Design and Conduct of Commercial Clinical Trials
Harold E Glass, Lucas M Glass, Jeffrey J DiFrancesco
IEEE Transactions on Knowledge and Data Engineering
|
January 2, 2023
MOLER: Incorporate Molecule-Level Reward to Enhance Deep Generative Model for Molecule Optimization
Tianfan Fu, Cao Xiao, Lucas M Glass, et al.
Journal of the American Medical Informatics Association : JAMIA
|
June 18, 2020
Dr. Agent: Clinical predictive model via mimicked second opinions
Junyi Gao, Cao Xiao, Lucas M Glass, et al.
Bioinformatics (Oxford, England)
|
October 18, 2020
MolTrans: Molecular Interaction Transformer for drug-target interaction prediction
Kexin Huang, Cao Xiao, Lucas M Glass, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Pharmaceutical Organizational Size and Phase 3 Clinical Trial Completion Times
Harold E Glass, Lucas M Glass, Phuong Tran, et al.
Scientific Reports
|
December 4, 2020
SkipGNN: predicting molecular interactions with skip-graph networks
Kexin Huang, Cao Xiao, Lucas M Glass, et al.
Patterns (New York, N.Y.)
|
April 25, 2022
HINT: Hierarchical interaction network for clinical-trial-outcome predictions
Tianfan Fu, Kexin Huang, Cao Xiao, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Are Phase 3 Clinical Trials Really Becoming More Complex?
Harold E Glass, Jeffrey J DiFrancesco, Lucas M Glass, et al.
Journal of the American Medical Informatics Association : JAMIA
|
October 30, 2020
FLANNEL (Focal Loss bAsed Neural Network EnsembLe) for COVID-19 detection
Zhi Qiao, Austin Bae, Lucas M Glass, et al.
Page
of 2